BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37287368)

  • 1. Valosin-containing protein (VCP/p97) is prognostically unfavorable in pediatric AML, and negatively correlates with unfolded protein response proteins IRE1 and GRP78: A report from the Children's Oncology Group.
    Hoff FW; Qiu Y; Brown BD; Gerbing RB; Leonti AR; Ries RE; Gamis AS; Aplenc R; Kolb EA; Alonzo TA; Meshinchi S; Jenkins GN; Horton TM; Kornblau SM
    Proteomics Clin Appl; 2023 Nov; 17(6):e2200109. PubMed ID: 37287368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between salt-inducible kinase 2 (SIK2) and p97/valosin-containing protein (VCP) regulates endoplasmic reticulum (ER)-associated protein degradation in mammalian cells.
    Yang FC; Lin YH; Chen WH; Huang JY; Chang HY; Su SH; Wang HT; Chiang CY; Hsu PH; Tsai MD; Tan BC; Lee SC
    J Biol Chem; 2013 Nov; 288(47):33861-33872. PubMed ID: 24129571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF-κB subunit RelA.
    van Dijk AD; Hoff FW; Qiu Y; Gerbing RB; Gamis AS; Aplenc R; Kolb EA; Alonzo TA; Meshinchi S; Jenkins GN; de Bont ESJM; Kornblau SM; Horton TM
    Proteomics Clin Appl; 2022 Mar; 16(2):e2100072. PubMed ID: 34719869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valosin-Containing Protein (VCP)/p97: A Prognostic Biomarker and Therapeutic Target in Cancer.
    Costantini S; Capone F; Polo A; Bagnara P; Budillon A
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRSK2 is a valosin-containing protein (VCP)-interacting protein that affects VCP functioning in endoplasmic reticulum-associated degradation.
    Wang Y; Wan B; Zhou J; Li R; Yu L
    Biotechnol Lett; 2013 Dec; 35(12):1983-9. PubMed ID: 23907667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Human Cytomegalovirus Transmembrane Protein pUL50 Induces Loss of VCP/p97 and Is Regulated by a Small Isoform of pUL50.
    Lee MK; Hyeon S; Ahn JH
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VCP inhibition induces an unfolded protein response and apoptosis in human acute myeloid leukemia cells.
    Szczęśniak PP; Heidelberger JB; Serve H; Beli P; Wagner SA
    PLoS One; 2022; 17(4):e0266478. PubMed ID: 35385564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells.
    Wójcik C; Rowicka M; Kudlicki A; Nowis D; McConnell E; Kujawa M; DeMartino GN
    Mol Biol Cell; 2006 Nov; 17(11):4606-18. PubMed ID: 16914519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AAA ATPase p97/valosin-containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum-associated degradation.
    Zhong X; Shen Y; Ballar P; Apostolou A; Agami R; Fang S
    J Biol Chem; 2004 Oct; 279(44):45676-84. PubMed ID: 15331598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selenoprotein S-dependent Selenoprotein K Binding to p97(VCP) Protein Is Essential for Endoplasmic Reticulum-associated Degradation.
    Lee JH; Park KJ; Jang JK; Jeon YH; Ko KY; Kwon JH; Lee SR; Kim IY
    J Biol Chem; 2015 Dec; 290(50):29941-52. PubMed ID: 26504085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting valosin-containing protein enhances the efficacy of radiation therapy in esophageal squamous cell carcinoma.
    Luo H; Song H; Mao R; Gao Q; Feng Z; Wang N; Song S; Jiao R; Ni P; Ge H
    Cancer Sci; 2019 Nov; 110(11):3464-3475. PubMed ID: 31454136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral mediated tethering to SEL1L facilitates ER-associated degradation of IRE1.
    Hinte F; Müller J; Brune W
    J Virol; 2021 Mar; 95(8):. PubMed ID: 33472927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock factor 1 (HSF1-pSer326) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG report.
    Hoff FW; van Dijk AD; Qiu Y; Ruvolo PP; Gerbing RB; Leonti AR; Jenkins GN; Gamis AS; Aplenc R; Kolb EA; Alonzo TA; Meshinchi S; de Bont ESJM; Bruggeman SWM; Kornblau SM; Horton TM
    Blood; 2021 Feb; 137(8):1050-1060. PubMed ID: 32959058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of ER-associated degradation via p97/VCP-interacting motif.
    Ballar P; Fang S
    Biochem Soc Trans; 2008 Oct; 36(Pt 5):818-22. PubMed ID: 18793143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ufd1 phosphorylation at serine 229 negatively regulates endoplasmic reticulum-associated degradation by inhibiting the interaction of Ufd1 with VCP.
    Nguyen QT; Choi J; Yang JK; Lee SY
    Biochem J; 2019 Sep; 476(18):2561-2577. PubMed ID: 31477623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of endoplasmic reticulum-associated degradation rescues DeltaF508-cystic fibrosis transmembrane regulator and suppresses interleukin-8 levels: therapeutic implications.
    Vij N; Fang S; Zeitlin PL
    J Biol Chem; 2006 Jun; 281(25):17369-17378. PubMed ID: 16621797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Retrotranslocation Assay That Predicts Defective VCP/p97-Mediated Trafficking of a Retroviral Signal Peptide.
    Das P; Xu WK; Gautam AKS; Lozano MM; Dudley JP
    mBio; 2022 Feb; 13(1):e0295321. PubMed ID: 35089078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VCP inhibitors induce endoplasmic reticulum stress, cause cell cycle arrest, trigger caspase-mediated cell death and synergistically kill ovarian cancer cells in combination with Salubrinal.
    Bastola P; Neums L; Schoenen FJ; Chien J
    Mol Oncol; 2016 Dec; 10(10):1559-1574. PubMed ID: 27729194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib-sensitive and -resistant multiple myeloma cells.
    Nishimura N; Radwan MO; Amano M; Endo S; Fujii E; Hayashi H; Ueno S; Ueno N; Tatetsu H; Hata H; Okamoto Y; Otsuka M; Mitsuya H; Matsuoka M; Okuno Y
    Cancer Sci; 2019 Oct; 110(10):3275-3287. PubMed ID: 31368616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic Mutations in the Valosin-containing Protein/p97(VCP) N-domain Inhibit the SUMOylation of VCP and Lead to Impaired Stress Response.
    Wang T; Xu W; Qin M; Yang Y; Bao P; Shen F; Zhang Z; Xu J
    J Biol Chem; 2016 Jul; 291(27):14373-14384. PubMed ID: 27226613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.